Answers are grounded in this paper and cite their sources.
In the past three decades, there has been significant improvements in the diagnosis and management of acute myeloid leukaemia. Cytogenetic and molecular genetic modalities have now enabled physicians to identify and plan appropriate management protocols for patients according to genetic profile
No takes yet. Share an insight, caveat, or question.
Haidary et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: